Earnings Feed
Start Free
Home/Filings/4/0001209191-11-028783
4//SEC Filing

Seiwert Scott 4

Accession 0001209191-11-028783

CIK 0001087432other
View on SEC.govCompany Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 9:51 PM ET

Size

22.0 KB

Accession

0001209191-11-028783

Insider Transaction Report

Form 4
Period: 2011-05-12
INTERMUNE INCITMN
Seiwert Scott
VP, Rsearch/ Preclinical Dev.
Transactions
  • Exercise/Conversion

    Common Stock

    2011-05-12$15.40/sh+9,500$146,300→ 72,765 total
  • Exercise/Conversion

    Common Stock

    2011-05-12$11.93/sh+15,000$178,950→ 87,765 total
  • Exercise/Conversion

    Common Stock

    2011-05-12$22.16/sh+22,980$509,237→ 118,413 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-05-12−15,000→ 0 total
    Exercise: $11.93Exp: 2015-05-26→ Common Stock (15,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-05-12−5,468→ 2,032 total
    Exercise: $15.34Exp: 2018-05-13→ Common Stock (5,468 underlying)
  • Exercise/Conversion

    Common Stock

    2011-05-12$16.93/sh+2,200$37,246→ 95,433 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-05-12−9,500→ 0 total
    Exercise: $15.40Exp: 2016-06-30→ Common Stock (9,500 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-05-12−22,980→ 0 total
    Exercise: $22.16Exp: 2016-12-12→ Common Stock (22,980 underlying)
  • Exercise/Conversion

    Common Stock

    2011-05-12$15.34/sh+5,468$83,879→ 93,233 total
  • Sale

    Common Stock

    2011-05-12$39.13/sh−71,443$2,795,229→ 46,970 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-05-12−2,200→ 0 total
    Exercise: $16.93Exp: 2013-06-16→ Common Stock (2,200 underlying)
Footnotes (3)
  • [F1]Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $38.75 to $39.35 per share. Full information on the numbers of shares sold at each sale price is available upon request.
  • [F2]Fully exercisable.
  • [F3]Twenty-five percent (25%) of the total number of shares subject to the stock option vest and become exercisable on the first anniversary of the grant date. The remainder of the option shares vests and becomes exercisable cumulatively in equal monthly installments over the following thirty-six (36) months.

Documents

1 file

Issuer

INTERMUNE INC

CIK 0001087432

→
Entity typeother

Related Parties

1
  • filerCIK 0001458451

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 9:51 PM ET
Size
22.0 KB
View on SEC.gov